Quinn Opportunity Partners LLC - GLOBAL CORD BLOOD CORPORATIO ownership

GLOBAL CORD BLOOD CORPORATIO's ticker is CO and the CUSIP is G39342103. A total of 33 filers reported holding GLOBAL CORD BLOOD CORPORATIO in Q1 2021. The put-call ratio across all filers is 2.04 and the average weighting 0.0%.

Quarter-by-quarter ownership
Quinn Opportunity Partners LLC ownership history of GLOBAL CORD BLOOD CORPORATIO
ValueSharesWeighting
Q1 2023$0324,4940.0%0.00%
Q4 2022$0
-100.0%
324,4940.0%0.00%
-100.0%
Q3 2022$969,458
+0.9%
324,4940.0%0.11%
+31.0%
Q2 2022$961,000
-23.1%
324,4940.0%0.08%
+55.6%
Q1 2022$1,249,000
-8.2%
324,4940.0%0.05%
-34.9%
Q4 2021$1,360,000
-10.2%
324,4940.0%0.08%
-14.4%
Q3 2021$1,515,000
-12.6%
324,4940.0%0.10%
-10.2%
Q2 2021$1,733,000
+17.9%
324,4940.0%0.11%
+16.1%
Q1 2021$1,470,000
+49.8%
324,494
+22.7%
0.09%
+12.0%
Q4 2020$981,000
+4.8%
264,4940.0%0.08%
-17.0%
Q3 2020$936,000
+13.0%
264,494
-0.9%
0.10%
-3.8%
Q2 2020$828,000
-2.5%
266,9420.0%0.10%
-18.8%
Q1 2020$849,000
-70.0%
266,942
-52.8%
0.13%
-31.2%
Q4 2019$2,830,000
+116.5%
566,052
+109.6%
0.19%
+17.0%
Q3 2019$1,307,000
-12.9%
270,042
+4.0%
0.16%
-15.0%
Q2 2019$1,501,000
-15.8%
259,764
+2.3%
0.19%
-23.4%
Q1 2019$1,783,000
+8.9%
253,9640.0%0.24%
+7.0%
Q4 2018$1,638,000
-9.5%
253,964
-1.9%
0.23%
-11.3%
Q3 2018$1,810,000
+10.0%
258,964
+49.3%
0.26%
+17.4%
Q2 2018$1,646,000
+19.5%
173,484
+28.5%
0.22%
+23.7%
Q1 2018$1,377,000135,0000.18%
Other shareholders
GLOBAL CORD BLOOD CORPORATIO shareholders Q1 2021
NameSharesValueWeighting ↓
JAYHAWK CAPITAL MANAGEMENT, L.L.C. 13,425,419$94,246,000100.00%
Lingohr Asset Management GmbH 62,100$422,0000.44%
Rock Springs Capital Management LP 925,000$6,494,0000.25%
Quinn Opportunity Partners LLC 253,964$1,783,0000.24%
Mosaic Family Wealth, LLC 12,275$86,0000.04%
Man Group plc 699,641$4,911,0000.02%
Renaissance Technologies 2,797,500$19,638,0000.02%
OXFORD ASSET MANAGEMENT LLP 120,000$842,0000.02%
GSA CAPITAL PARTNERS LLP 19,567$137,0000.01%
SG Americas Securities, LLC 107,931$758,0000.01%
View complete list of GLOBAL CORD BLOOD CORPORATIO shareholders